In fact, HP-EVOO improved insulin sensitivity in obese rats on an HFD, as manifested by a decrease in the insulin resistance index and the homeostatic model assessment for insulin resistance (HOMA-IR) and an increase in activity of the insulin degrading enzyme (IDE) in the liver. The gene discussed is IDE; the disease is Insulin resistance.